These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24122637)

  • 1. Favorable pharmacokinetics of biolimus A9 after deployment of Nobori stent for coronary artery disease: insights from Nobori PK study in Japanese subjects.
    Nakamura M; Otsuka Y; Ueda Y; Mitsudo K
    Cardiovasc Interv Ther; 2012 Jan; 27(1):24-30. PubMed ID: 24122637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries.
    Kadota K; Muramatsu T; Iwabuchi M; Saito S; Hayashi Y; Ikari Y; Nanto S; Fujii K; Inoue N; Namiki A; Kimura T; Mitsudo K
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):789-96. PubMed ID: 21805606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study.
    Ostojic M; Sagic D; Jung R; Zhang YL; Nedeljkovic M; Mangovski L; Stojkovic S; Debeljacki D; Colic M; Beleslin B; Milosavljevic B; Orlic D; Topic D; Karanovic N; Paunovic D; Christians U;
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):901-8. PubMed ID: 19016466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study.
    Andreasen LN; Holm NR; Balleby IR; Krusell LR; Maeng M; Jakobsen L; Veien KT; Hansen KN; Kristensen SD; Hjort J; Kaltoft A; Dijkstra J; Terkelsen CJ; Lassen JF; Madsen M; Bøtker HE; Jensen LO; Christiansen EH
    Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):329-338. PubMed ID: 28369332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.
    Pendyala LK; Matsumoto D; Shinke T; Iwasaki T; Sugimoto R; Hou D; Chen JP; Singh J; King SB; Chronos N; Li J
    JACC Cardiovasc Interv; 2012 Apr; 5(4):436-44. PubMed ID: 22516402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial.
    Ellert J; Maeng M; Raungaard B; Hansen KN; Kahlert J; Jensen SE; Bøtker HE; Hansen HS; Lassen JF; Christiansen EH; Jensen LO
    Coron Artery Dis; 2020 Sep; 31(6):485-492. PubMed ID: 32271243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial.
    Lee JY; Park DW; Kim YH; Ahn JM; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Yang TH; Lee BK; Lee NH; Yang JY; Shin WY; Park HS; Kim KS; Hur SH; Lee SY; Park JS; Choi YS; Lee SU; Her SH; Park SJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):322-9. PubMed ID: 24823426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with BioMatrix BES and other DES in all-comers setting: a retrospective overview.
    Goyal BK; Kalmath BC; Kawar R; Sharma A; Khemnar B; Rangnekar H
    Indian Heart J; 2013 Dec; 65(6):678-82. PubMed ID: 24407537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.
    Seth A; Hiremath S; Dani S; Kapoor S; Jain RK; Abhaichand R; Trivedi S; Kaul U; Patil A; Khemnar B; Rangnekar H
    Indian Heart J; 2013; 65(5):586-92. PubMed ID: 24206882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study.
    Ostojic MC; Perisic Z; Sagic D; Jung R; Zhang YL; Bendrick-Peart J; Betts R; Christians U;
    Eur J Clin Pharmacol; 2011 Apr; 67(4):389-398. PubMed ID: 20963405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial.
    Jensen LO; Thayssen P; Maeng M; Ravkilde J; Hansen HS; Jensen SE; Bøtker HE; Berencsi K; Lassen JF; Christiansen EH
    Am Heart J; 2015 Aug; 170(2):210-5. PubMed ID: 26299216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcome of biolimus eluting stent with biodegradable polymer in all comers: the Italian Nobori Stent Prospective Registry.
    Godino C; Parenti DZ; Regazzoli D; Rutigliano D; Lucisano L; Viani GM; Spartera M; Chieffo A; Donahue M; Cappelletti A; Locuratolo N; Parisi R; Fattori R; Presbitero P; Margonato A; Briguori C; Sardella G; Colombo A;
    Int J Cardiol; 2014 Nov; 177(1):11-6. PubMed ID: 25499324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.
    Wykrzykowska JJ; Serruys PW; Onuma Y; de Vries T; van Es GA; Buszman P; Linke A; Ischinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice MC; di Mario C; van Geuns RJ; Juni P; Windecker S
    JACC Cardiovasc Interv; 2009 Sep; 2(9):861-70. PubMed ID: 19778775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pharmacokinetics of the limus-eluting stents in Japanese patients.
    Otsuka Y; Saito S; Nakamura M; Shuto H; Mitsudo K
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1078-85. PubMed ID: 21538783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation.
    Konishi A; Shinke T; Otake H; Takaya T; Osue T; Kinutani H; Kuroda M; Takahashi H; Terashita D; Shite J; Hirata K
    Can J Cardiol; 2015 Aug; 31(8):980-8. PubMed ID: 26117623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
    Christiansen EH; Jensen LO; Thayssen P; Tilsted HH; Krusell LR; Hansen KN; Kaltoft A; Maeng M; Kristensen SD; Bøtker HE; Terkelsen CJ; Villadsen AB; Ravkilde J; Aarøe J; Madsen M; Thuesen L; Lassen JF;
    Lancet; 2013 Feb; 381(9867):661-9. PubMed ID: 23374649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.